News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Wolfe Laboratories Inc. Hires a New Vice President of Preclinical Development
September 17, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WATERTOWN, Mass.--(BUSINESS WIRE)--Wolfe Laboratories, Inc. (WLI), a pharmaceutical development company, announced today that Roger Rush, Ph.D has joined the company as Vice President of Preclinical Development.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Deals
Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset
October 5, 2026
·
2 min read
·
Gabrielle Masson
Deals
CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential
October 5, 2026
·
2 min read
·
Tristan Manalac
Insights
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
October 5, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Layoff Tracker
Foghorn cuts 40% of workforce
October 2, 2026
·
98 min read
·
BioSpace Editorial Staff
